151 related articles for article (PubMed ID: 22666745)
1. Ki-67 expression score correlates to survival rate in gastrointestinal stromal tumors (GIST).
Artigiani Neto R; Logullo AF; Stávale JN; Lourenço LG
Acta Cir Bras; 2012 May; 27(5):315-21. PubMed ID: 22666745
[TBL] [Abstract][Full Text] [Related]
2. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors.
Liang YM; Li XH; Li WM; Lu YY
World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697
[TBL] [Abstract][Full Text] [Related]
4. Exon 11 mutations, Ki67, and p16(INK4A) as predictors of prognosis in patients with GIST.
Cerski MR; Pereira F; Matte US; Oliveira FH; Crusius FL; Waengertner LE; Osvaldt A; Fornari F; Meurer L
Pathol Res Pract; 2011 Nov; 207(11):701-6. PubMed ID: 22024151
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors.
Jiang J; Jin MS; Suo J; Wang YP; He L; Cao XY
World J Gastroenterol; 2012 May; 18(20):2569-75. PubMed ID: 22654456
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 labeling index may be a promising indicator to identify "very high-risk" gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients.
Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
Hum Pathol; 2018 Apr; 74():17-24. PubMed ID: 28962945
[TBL] [Abstract][Full Text] [Related]
7. Duodenal gastrointestinal stromal tumor: clinical, pathologic, immunohistochemical characteristics, and surgical prognosis.
Yang WL; Yu JR; Wu YJ; Zhu KK; Ding W; Gao Y; Shen QY; Lv KZ; Zhang Q; Yang XJ
J Surg Oncol; 2009 Dec; 100(7):606-10. PubMed ID: 19697360
[TBL] [Abstract][Full Text] [Related]
8. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic features of gastrointestinal stromal tumor with synchronous carcinoma].
Sun XY; Wu QS; Geng ZH; Li Q; Wang LL; Li XG
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):739-43. PubMed ID: 24447550
[TBL] [Abstract][Full Text] [Related]
10. Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parameters.
Gumurdulu D; Erdogan S; Kayaselcuk F; Seydaoglu G; Parsak CK; Demircan O; Tuncer I
World J Gastroenterol; 2007 Jan; 13(3):426-31. PubMed ID: 17230613
[TBL] [Abstract][Full Text] [Related]
11. Biological analysis of gastrointestinal stromal tumors.
Noguchi T; Sato T; Takeno S; Uchida Y; Kashima K; Yokoyama S; Müller W
Oncol Rep; 2002; 9(6):1277-82. PubMed ID: 12375034
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal stromal tumors. A clinicopathological study.
Alghamdi HM; Amr SS; Shawarby MA; Sheikh SS; Alsayyah AA; Alamri AM; Ismail MH; Almarhabi A; Alrefaee MA; Ahmed MI
Saudi Med J; 2019 Feb; 40(2):126-130. PubMed ID: 30723856
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical diagnosis of gastrointestinal stromal tumors - an analysis of 80 cases from 2004 to 2010.
Kiśluk J; Gryko M; Guzińska-Ustymowicz K; Kemona A; Kędra B
Adv Clin Exp Med; 2013; 22(1):33-9. PubMed ID: 23468260
[TBL] [Abstract][Full Text] [Related]
15. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
16. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
17. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between expression of cyclin D1, Ki-67 and bcl-2 and biologic behavior in CD117-positive gastrointestinal stromal tumors].
Sun M; Zhang XY; Zou HJ; Sun YX; Li DF
Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):788-90. PubMed ID: 16545187
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic significance of Ki-67 expression in patients undergoing surgical resection for gastrointestinal stromal tumor].
Jeong SY; Park WW; Kim YS; Park YI; Kim SH; Yoon WJ; Moon JS; Lee BM; Hong SW; Kang YK
Korean J Gastroenterol; 2014 Aug; 64(2):87-92. PubMed ID: 25168050
[TBL] [Abstract][Full Text] [Related]
20. [Study on associated biomarkers influencing recurrence, metastasis and prognosis in patients with gastrointestinal stromal tumors after complete resection].
Fang YJ; Zhang RX; Luo RZ; Ou QJ; Wan DS; Pan ZZ; Wu XJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):242-6. PubMed ID: 23536344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
